跳至主要内容
临床试验/NCT01946269
NCT01946269Unknown3 期

Goal-directed Resuscitation in High-risk Patients Undergoing Major Cancer Surgery: a Controlled and Randomized Study

University of Sao Paulo2 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2013年9月最近更新:
适应症

试验速览

阶段
3 期
入组人数
128
试验地点
2
主要终点
Composite endpoint of death or major postoperative complications

研究概览

简要总结

The purpose of this study is to determine whether a goal-directed resuscitation therapy within the first 8 hours after major abdominal cancer surgery reduces postoperative complications compared to a standard therapy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients admitted to ICU in immediate postoperatory of major abdominal surgery for cancer treatment
  • Age over 18 years-old

排除标准

  • Weight under 55 kilograms or over 140 kilograms;
  • Contra-indication for invasive hemodynamic monitoring;
  • Expected ICU permanence less than 24 hours;
  • Active bleeding
  • Vasoplegic shock with noradrenaline dose higher than 1mcg/kg/min
  • Enrolled in other study
  • Refuse to consent

结局指标

主要结局

Composite endpoint of death or major postoperative complications

时间窗: 30 days after randomization

Death or one of the following complications: stroke, renal failure, respiratory complications, cardiovascular complications, deep wound infection and reoperation for any reason.

次要结局

  • Duration of ICU stay and hospital stay(30 days after randomization)
  • Tissue hypoperfusion markers(7 days after randomization)
  • Daily SOFA score(7 days after randomization)
  • Cardiovascular complications(30 days after randomization)
  • Respiratory complications(30 days after randomization)
  • Severe Renal complication(30 days after randomization)
  • Neurological complications(30 days after randomization)
  • Severe infectious complications(30 days after randomization)
  • Surgical complications(30 days after randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ludhmila Abrahão Hajjar

Principal Investigator

University of Sao Paulo

研究点 (2)

Loading locations...

相似试验

Goal-Directed Therapy in Cancer Surgery | 临床试验